SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-000394
Filing Date
2020-02-07
Accepted
2020-02-07 14:45:12
Documents
4
Period of Report
2019-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cpmd_8k.htm 8-K 18649
2 AMENDING AGREEMENT NO. 2 TO SHARE PURCHASE AGREEMENT cpmd_ex1005.htm EX-10.5 30593
3 PRESS RELEASE cpmd_ex9906.htm EX-99.6 18154
4 GRAPHIC image_004.jpg GRAPHIC 2563
  Complete submission text file 0001683168-20-000394.txt   72524
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 20586889
SIC: 2834 Pharmaceutical Preparations